Evolent Health Files 2024 10-K
Ticker: EVH · Form: 10-K · Filed: Feb 21, 2025 · CIK: 1628908
| Field | Detail |
|---|---|
| Company | Evolent Health, INC. (EVH) |
| Form Type | 10-K |
| Filed Date | Feb 21, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, financials
TL;DR
EVH 2024 10-K filed. Full financials out.
AI Summary
Evolent Health, Inc. filed its 2024 10-K on February 21, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in Delaware, is headquartered at 1812 North Moore St, Suite 1705, Arlington, VA. The filing covers financial performance and business operations for the period, with specific financial data and disclosures to be detailed within the full report.
Why It Matters
This 10-K filing provides a comprehensive overview of Evolent Health's financial health and strategic direction for the fiscal year 2024, crucial for investors and stakeholders to assess performance and future prospects.
Risk Assessment
Risk Level: medium — This is a standard annual financial filing, and the risk level is neutral as it contains factual financial information rather than forward-looking statements or significant new disclosures.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-02-21 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Evolent Health, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-21 (date) — Filing date
- 1812 North Moore St, Suite 1705, Arlington, VA (address) — Company headquarters
FAQ
What were Evolent Health's total revenues for the fiscal year ended December 31, 2024?
The provided text does not contain specific revenue figures for the fiscal year ended December 31, 2024. The full 10-K document would contain this information.
What is Evolent Health's net income or loss for the fiscal year ended December 31, 2024?
The provided text does not specify Evolent Health's net income or loss for the fiscal year ended December 31, 2024. This detail would be found within the financial statements of the full filing.
What were the significant changes in Evolent Health's balance sheet items, such as cash or debt, as of December 31, 2024, compared to the previous year?
The provided text does not include comparative balance sheet data for December 31, 2024, versus the prior year. Detailed balance sheet information is available in the full 10-K filing.
Did Evolent Health engage in any business combinations or contingent consideration arrangements during the fiscal year 2024?
The filing references accounting standards related to 'BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', suggesting such arrangements may be relevant, but specific details for FY2024 are not in the provided snippet.
What is Evolent Health's stock ticker symbol?
The provided text does not explicitly state Evolent Health's stock ticker symbol, but the SEC file number is 001-37415.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 21, 2025 regarding Evolent Health, Inc. (EVH).